Tradestie Institutional Equity Comparison Engine

GRML vs TNON โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TNON Overall Edge

TNON Captures Institutional Edge (1โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tenon Medical, Inc. Common Stock (TNON) driven by superior Growth & Margin while GRML counters with relative strength in Momentum & Technical. Fundamentally, GRML trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus TNON at N/M Forward P/E and -228.0% operating margin (+126.8% YoY). In options structure, GRML sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TNON sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
GRML N/M vs TNON N/M Fwd P/E
Growth & Margin Winner TNON
Op Margin N/A vs -228.0% ยท YoY N/A vs +126.8%
Momentum & Technical Winner GRML
1Y +647.9% vs +13.1% ยท 52W Pos 18% vs 7%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GRML US Equity
GRML
Institutional Equity
$3.50
-3.05% 1D
Market Cap N/A
1M Return -41.67%
1Y Return +647.86%
Forward P/E N/M
Unified AI Score
56.8 / 100 HOLD
Tech 60.0 Fund 57.0 Flow 50.0 Mom 60.0
TNON NASDAQ
Tenon Medical, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.33
-5.32% 1D
Market Cap $3.8M
1M Return -50.56%
1Y Return +13.14%
Forward P/E N/M
Unified AI Score
45.0 / 100 HOLD
Tech 33.0 Fund 50.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GRML +647.86% TNON +13.14% Spread: +582.06 pp (GRML Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GRML TTM Op. Margin: N/A TNON TTM Op. Margin: -228.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GRML vs TNON. Trailing 12-month operating profitability (GRML N/A vs TNON -228.0%) and valuation multiples (GRML N/M vs TNON N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GRML (3) vs TNON (5)
Institutional Metric GRML TNON Criterion Row Winner
Market Capitalization Scale N/A $3.8M Larger Scale TNON
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +126.8% Higher Growth TNON
Operating Margin (TTM) Profitability N/A -228.0% Higher Margin TNON
Net Profit Margin Profitability N/A -257.9% Higher Margin TNON
Return on Equity (ROE) Capital Efficiency N/A -551.2% Higher ROE TNON
52-Week Range Position Momentum 18% ($0โ€“$18) 7% ($0โ€“$18) Stronger Trend GRML
Beta / 30D Volatility Risk Regime -5.29ฮฒ ยท 95% Vol -1.54ฮฒ ยท 106% Vol Lower Realized Risk GRML
Unified Institutional Score Composite Signal 56.8 / 100 (HOLD) 45.0 / 100 (HOLD) Higher Composite GRML

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GRML vs TNON Buy Guide
GRML UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GRML Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TNON UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TNON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GRML nor TNON registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.